ABNORMAL SEX STEROID-SECRETION AND BINDING IN MASSIVELY OBESE WOMEN
ABNORMAL SEX STEROID-SECRETION AND BINDING IN MASSIVELY OBESE WOMEN
复制标题
DOI:
10.1111/j.1365-2265.1980.tb02721.x
复制
发表时间:
1980-01-01
影响因子:
3.2
通讯作者:
JEFFCOATE, SL
中科院分区:
文献类型:
--
作者:
KOPELMAN, PG;PILKINGTON, TRE;JEFFCOATE, SL
The plasma concentrations of sex steroids and sex hormone-binding globulin (SHBG) were measured in 23 massively obese women and 10 age-matched lean female volunteers. In the obese women increased plasma testosterone (obese 3.2 .+-. 0.5 nM controls 1.7 .+-. 0.5 nM, P < 0.3) and androstenedione concentrations (obese 9.7 .+-. 1.2 nM, controls 4.4 .+-. 0.6 nM, P = < 0.01) an increased ratio of estrone:estradiol (obese 2.4 .+-. 0.4, controls 1.0 .+-. 0.1, P = < 0.1) and decreased SHBG levels (obese 30 .+-. 4 nM, controls 60 .+-. 8 nM, P = < 0.001) were found. Obesity differed from the polycystic ovary syndrome (in which a similar pattern of changes of sex steroid concentrations and binding are seen) in that it was associated with normal increases in serum luteinizing hormone (LH) follicle stimulating hormone (FSH) levels in response to the administration of LHRH [LH releasing hormone]. The common occurrence of menstrual abnormalities in obesity results from abnormal secretion and binding of sex steroids. In addition, the unaltered secretion of LH and FSH in the presence of such changes is evidence for a disorder of hypothalamic function.